DrugPatentWatch Database Preview

Corcept Therap Company Profile

« Back to Dashboard

What is the competitive landscape for CORCEPT THERAP, and what generic alternatives to CORCEPT THERAP drugs are available?

CORCEPT THERAP has one approved drug.

There are eight US patents protecting CORCEPT THERAP drugs.

There are fifteen patent family members on CORCEPT THERAP drugs in eight countries.

Summary for Corcept Therap

International Patents:	15
US Patents:	8
Tradenames:	1
Ingredients:	1
NDAs:	1
Patent Litigation for Corcept Therap:	See patent lawsuits for Corcept Therap

Drugs and US Patents for Corcept Therap

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Corcept Therap	KORLYM	mifepristone	TABLET;ORAL	202107-001	Feb 17, 2012		RX	Yes	Yes	10,006,924
Corcept Therap	KORLYM	mifepristone	TABLET;ORAL	202107-001	Feb 17, 2012		RX	Yes	Yes	10,151,763
Corcept Therap	KORLYM	mifepristone	TABLET;ORAL	202107-001	Feb 17, 2012		RX	Yes	Yes	9,829,495
Corcept Therap	KORLYM	mifepristone	TABLET;ORAL	202107-001	Feb 17, 2012		RX	Yes	Yes
Corcept Therap	KORLYM	mifepristone	TABLET;ORAL	202107-001	Feb 17, 2012		RX	Yes	Yes	10,195,214
Corcept Therap	KORLYM	mifepristone	TABLET;ORAL	202107-001	Feb 17, 2012		RX	Yes	Yes	8,921,348

International Patents for Corcept Therap Drugs

Country	Patent Number	Estimated Expiration
European Patent Office	3405101
European Patent Office	3335043
Singapore	11201806101S
World Intellectual Property Organization (WIPO)	2017027851
Canada	2994422
Australia	2017210156

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Corcept Therap